Skip to content

General Discussion

A place to talk about whatever you want

5 Topics 12 Posts
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB), including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
  • Product is "in stock" claim

    1
    0 Votes
    1 Posts
    21 Views
    No one has replied
  • PAAB Code - Post hoc analysis

    2
    0 Votes
    2 Posts
    108 Views
    Jennifer CarrollJ
    Hello @msargeant Apologies for not seeing this question sooner. Per 3.1.1, post-hoc analysis are generally not considered acceptable evidence at this time. The circumstance in which post-hoc analyses would be considered acceptable is outlined in the statement that follows that copy which states “Data included in the TMA may be acceptable”. HTH.
  • Clarification on Product Available now! message in the APS

    3
    0 Votes
    3 Posts
    432 Views
    S
    Thank you @Jennifer-Carroll!
  • Clarification on indication inclusion in multi-Product APS

    5
    0 Votes
    5 Posts
    658 Views
    S
    Thank you @Jennifer-Carroll. This is very helpful!
  • Welcome to your NodeBB!

    1
    0 Votes
    1 Posts
    169 Views
    No one has replied
  • Healthcare Professional Tour

    1
    0 Votes
    1 Posts
    17k Views
    No one has replied
  • Industry Tour

    1
    0 Votes
    1 Posts
    7k Views
    No one has replied
  • Patient Tour

    1
    0 Votes
    1 Posts
    2k Views
    No one has replied
  • This topic is deleted!

    1
    0 Votes
    1 Posts
    100 Views
    No one has replied